Surgical site injection of liposomal bupivacaine reduces 90-day incidence of major complications after hip fracture: a nonrandomized trial
With surgical site injection of LB, patient might have reduced incidence of major complications. The benefits of LB regarding all-cause mortality and delirium were not observed in this study, possibly due to insufficient power. Future randomized clinical trials with larger sample sizes were warranted by the current study.
Authors
- Hongyi Zhu (ORCID: https://orcid.org/0000-0001-9643-0790)
- Jiaqing Cao (ORCID: https://orcid.org/0000-0001-9262-4870)
- Dajun Jiang (ORCID: https://orcid.org/0000-0003-0377-6894)
- Qianying Cai (ORCID: https://orcid.org/0000-0002-9187-8315)
- Xiaolin Li (ORCID: https://orcid.org/0000-0002-1211-1037)
- Changqing Zhang (ORCID: https://orcid.org/0000-0002-7408-4126)
- Sen Lin (ORCID: https://orcid.org/0000-0002-6371-3927)
- Limin Zhao
- Weitao Jia
- Jinshan Zhang (ORCID: https://orcid.org/0000-0003-1496-4794)
Institutions
- Shanghai Jiao Tong University (CN)
- Longgang Central Hospital (CN)
- Jiangyin Traffic Planning Survey & Design Institute (China) (CN)
- Heilongjiang Provincial Hospital (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1097/js9.0000000000003808
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00